Zalando SE (DE000ZAL) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Zalando SE

BRIEF

published on 03/12/2024 at 18:06, 8 months 8 days ago

Zalando SE Initiates Share Buy-back Program to Support Stock Option Plans

Share Buy-back Corporate Finance Market Regulation Stock Option Program Zalando SE
PRESS RELEASE

published on 03/12/2024 at 18:01, 8 months 8 days ago

EQS-Adhoc: Zalando SE: Zalando Launches Share Buy-back for Stock Option Programs
Zalando SE initiates a share buy-back program for stock option programs to employees and Board members with up to six million shares and 100 million euros. The program starts on March 13, 2024, and ends on July 26, 2024

Share Buy-back Program Zalando SE Stock Option Programs Six Million Shares 100 Million Euros
PRESS RELEASE

published on 11/01/2023 at 19:49, 1 year ago

Zalando invests into inspiration, logistics and technology to boost future growth amid an increase in third quarter earnings
PRESS RELEASE

published on 11/01/2023 at 19:35, 1 year ago

EQS-Adhoc: Zalando SE: REVISED TOPLINE AND CONFIRMED ADJUSTED EBIT OUTLOOK FOR THE FULL YEAR 2023
PRESS RELEASE

published on 09/07/2023 at 17:21, 1 year 2 months ago

Zalando SE: Zalando Co-CEOs Robert Gentz and David Schneider Extend Contracts by Four Years
PRESS RELEASE

published on 08/03/2023 at 07:00, 1 year 3 months ago

Zalando SE: Zalando launches new brands and AI-powered size recommendations for customers in Q2, progressing on its strategy to be the Starting Point for Fashion
PRESS RELEASE

published on 05/24/2023 at 17:05, 1 year 5 months ago

Zalando SE: Annual General Meeting 2023
PRESS RELEASE

published on 05/04/2023 at 07:01, 1 year 6 months ago

Zalando SE: Zalando delivers growth and improved profitability as more customers buy through shopping club and partner business share increases
PRESS RELEASE

published on 04/11/2023 at 15:41, 1 year 7 months ago

Zalando SE: Kelly Bennett nominated as Zalando SE Supervisory Board Chairperson, Susanne Schröter-Crossan proposed as new member
PRESS RELEASE

published on 03/07/2023 at 06:59, 1 year 8 months ago

Zalando SE: Zalando grows customer base and progresses on platform transition in 2022, on path to be the Starting Point for Fashion

Accesswire

Published on 11/21/2024 at 13:30, 23 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 23 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 53 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 53 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 53 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 38 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 18 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 46 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 53 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 33 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE